Munich Re gives its views on the early stage cancer debate as part of the ABI's CI Statement of Best Practice consultation.
History shows that well established markets often come to a crossroads where changes are made. Competitive pressures inevitably drive more product options, quicker new business processes and put pressure on claims decisions, while prices get cheaper…something eventually has to give. Such pressure is building within the UK Critical Illness (CI) market and questions are being asked as to how we should proceed. This is not the first time that CI has been at such a crossroads: in 2002 a major...
Bill broadened to include insurable interest in cohabitants, group schemes and trusts
Thursday 4th October at The Hilton London Bankside
Early conversations about end-of-life care are crucial to ensure individuals living longer can make their own decisions, however right-to-die approaches vary all over the world
Group life, critical illness and income protection business bought from Munich Re